GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. The company's product portfolio includes prescription medicines and ...
From Pekingese to St. Bernard and greyhound, dogs come in such startling variety it's easy to forget they belong to the same species. The profusion of breeds today -- at least 150 -- reflects ...
Evolution determines who lives, who dies, and who passes traits on to the next generation. The process plays a critical role in our daily lives, yet it is one of the most overlooked -- and ...
United Airlines has undergone several logo changes since its inception in 1931. The iconic Saul Bass-designed tulip logo was ...
In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £16.50. The company’s shares closed last Friday at ...
(Reuters) -British drugmaker GSK announced on Thursday positive results from a mid-stage trial of its seasonal influenza ...
At GlaxoSmithKline, we never lose sight of ... we are pioneering innovation and evolution in trial design to complement the development of novel therapies. These cutting-edge approaches, such ...
J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50. The company’s shares opened today at p1,644. ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Knowledge. Community. Generosity. These three concepts capture Smith’s identity as an institution. Since its founding in 1871, Smith has remained at the forefront of higher education. A leader in ...
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...
View upcoming earnings forecasts and in-depth analysis of company forecasts.